Levels of sTM and PECAM were higher among patients with diabetes and chronic kidney disease than among patients without, patients with chronic heart failure had higher levels of PECAM-1 than patients without, whereas patients without COPD and hypertension had lower values of sTM and Syndecan-1, respectively (Additional File 2: Table S1). Here, PECAM1 is linked to Hypertension.